Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Praxis Precision Medicines, Inc.(PRAX) | 84,901 | 82,796 | -2,105 | $27.35M | $27.72M | 19.32% | +$365.0K |
| Whitehawk Therapeutics, Inc.(WHWK) | 3,410,402 | 4,685,912 | +1,275,510 | $11.77M | $21.46M | 14.96% | +$9.70M |
| Tango Therapeutics, Inc.(TNGX) | 441,831 | 390,949 | -50,882 | $9.24M | $12.22M | 8.52% | +$2.98M |
| Sutro Biopharma, Inc.(STRO) | 269,425 | 270,251 | +826 | $6.71M | $8.97M | 6.25% | +$2.26M |
| ArriVent BioPharma, Inc.(AVBP) | 0 | 218,694 | +218,694 | $0 | $7.60M | 5.29% | +$7.60M |
| 4d Molecular Therapeutics Inc | 0 | 507,801 | +507,801 | $0 | $6.75M | 4.71% | +$6.75M |
| Bright Minds Biosciences Inc.(DRUG) | 111,996 | 92,745 | -19,251 | $8.17M | $6.51M | 4.54% | -$1.66M |
| Ocular Therapeutix, Inc.(OCUL) | 592,108 | 532,481 | -59,627 | $5.02M | $5.23M | 3.64% | +$213.8K |
| Erasca, Inc.(ERAS) | 354,575 | 265,199 | -89,376 | $5.74M | $4.86M | 3.39% | -$878.6K |
| Surrozen, Inc.(SRZN) | 172,847 | 173,395 | +548 | $5.04M | $4.50M | 3.14% | -$535.4K |
| argenx SEADR(ARGX) | 4,690 | 4,705 | +15 | $3.42M | $4.37M | 3.04% | +$940.3K |
| MoonLake ImmunotherapeuticsCLASS ORD A(MLTX) | 191,760 | 215,652 | +23,892 | $3.57M | $4.20M | 2.93% | +$624.3K |
| Design Therapeutics, Inc.(DSGN) | 145,900 | 282,564 | +136,664 | $1.55M | $4.09M | 2.85% | +$2.54M |
| Minerva Neurosciences, Inc.(NERV) | 709,500 | 709,500 | 0 | $4.27M | $3.94M | 2.74% | -$337.0K |
| Taysha Gene Therapies, Inc.(TSHA) | 439,464 | 561,808 | +122,344 | $1.96M | $3.83M | 2.67% | +$1.86M |
| Avalyn Pharma Inc | 0 | 115,000 | +115,000 | $0 | $3.79M | 2.64% | +$3.79M |
| Avalo Therapeutics, Inc.(AVTX) | 60,808 | 186,308 | +125,500 | $907.9K | $3.44M | 2.40% | +$2.54M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 151,067 | 168,115 | +17,048 | $2.10M | $3.02M | 2.10% | +$919.5K |
| Artiva Biotherapeutics, Inc.(ARTV) | 0 | 260,416 | +260,416 | $0 | $2.53M | 1.76% | +$2.53M |
| Compass Therapeutics, Inc.(CMPX) | 849,076 | 595,213 | -253,863 | $4.49M | $1.30M | 0.91% | -$3.19M |
| United Therapeutics Corporation(UTHR) | 2,224 | 2,224 | 0 | $1.32M | $1.21M | 0.84% | -$113.8K |
| Contineum Therapeutics, Inc.CL A(CTNM) | 0 | 63,095 | +63,095 | $0 | $1.03M | 0.72% | +$1.03M |
| LB Pharmaceuticals Inc(LBRX) | 28,919 | 28,919 | 0 | $713.1K | $938.6K | 0.65% | +$225.4K |
| 4d Molecular Therapeutics Inc | 242,255 | 0 | -242,255 | $2.26M | $0 | — | -$2.26M |
| Entrada Therapeutics, Inc.(TRDA) | 89,358 | 0 | -89,358 | $1.13M | $0 | — | -$1.13M |
| IDEAYA Biosciences, Inc.(IDYA) | 48,234 | 0 | -48,234 | $1.61M | $0 | — | -$1.61M |
| Maze Therapeutics, Inc.(MAZE) | 19,335 | 0 | -19,335 | $577.1K | $0 | — | -$577.1K |
| Oculis Holding AG(OCS) | 98,339 | 0 | -98,339 | $2.61M | $0 | — | -$2.61M |
| Revolution Medicines, Inc.(RVMD) | 26,069 | 0 | -26,069 | $2.54M | $0 | — | -$2.54M |
| Terns Pharmaceuticals Inc | 495,772 | 0 | -495,772 | $26.14M | $0 | — | -$26.14M |
| Unicycive Therapeutics, Inc.(UNCY) | 57,959 | 0 | -57,959 | $381.4K | $0 | — | -$381.4K |